1 / 6

Telmisartan: Side effects, dosage, uses, and more

Telmisartan, medication sold under the brand name Micardis is consumed alone or in combination with other medications for decreasing the chances of heart attack or stroke among people above 55 years of age.

Pooja63
Download Presentation

Telmisartan: Side effects, dosage, uses, and more

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. TELMISARTAN MARKET Global Industry Analysis, Size, Share, Analysis, Growth, Forecast 2020 - 2030 Trends, and TMR Research www.tmrresearch.com

  2. TELMISARTAN MARKET 1MARKETOVERVIEW Telmisartan, medication sold under the brand name Micardis is consumed alone or in combination with other medications for decreasing the chances of heart attack or stroke among people above 55 years of age. The medication is consumed to control high blood pressure but cannot treat it. Telmisartan is an angiotensin II receptor blocker. TMR Research www.tmrresearch.com

  3. TELMISARTAN MARKET 2KEY TRENDS Loss in kidney functioning is one of the prime causes of death globally. With the primary reasons such as high blood pressure, diabetes, obesity, smoking, etc., need for telmisartan for moderately treating the kidney disease may grow further. TMR Research www.tmrresearch.com

  4. TELMISARTAN MARKET 3MARKETPOTENTIAL Telmisartan can be an alternative option with dual benefit for diabetes mellitus and hypertension. As per a research article published on ncbi.nlm.nih.gov, Telmisartan is reported to have a partial PPARy agonistic effect which modify the genes needed for insulin sensitization. Telmisartan can regulate glucose and lipid metabolism, therefore improvesinsulinresistance. TMR Research www.tmrresearch.com

  5. TELMISARTAN MARKET 4COMPETITVE ANALYSIS The key players in the sector include Mylan N.V., Jubilant Cadista, Sandoz International Pharmaceuticals, Inc., Torrent Aurobindo Pharma, Solco Pharmaceuticals, Inc., Medtronic Plc, KindWell Medical Equipment Co. Ltd., Neurovision Intersurgical GmbH, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries ltd., etc. GmbH, Zydus Ltd., Exelan Pharmaceuticals Healthcare, Medical Products, TMR Research www.tmrresearch.com

  6. TMR Research www.tmrresearch.com Sample Discount Check link in description

More Related